PlateReady™ HepG2
CryoLogyx PlateReady™ HepG2 Well Plates feature HepG2 cells cryopreserved directly on microplates and stored at −80 °C powered by patented CryoShield™ formulation, which ensure that the HepG2 cells are ready for immediate use following our straightforward three-step General Thaw-and-Use Protocol.
Assay Ready 24 hours post-thaw - immediate proliferative capacity, metabolic activity and membrane integrity
-
PlateReady™ HepG2 Plates contains human hepatocellular carcinoma derived cells cryopreserved directly adhered to microplates with the use of CryoLogyx’s patented CryoShield™ formulation. HepG2 cells perform many differentiated hepatic functions, making them the most widely used cell line in drug discovery for drug metabolism and hepatotoxicity testing.
-
PlateReady™ HepG2 Well Plates are provided at three different confluency levels:
Low: < 30% surface coverage.Medium: 40 – 60% cell surface coverage.
High: > 70% cell surface coverage.
-
24 well
96 well -
HPG20096PSCLHIG - High confluency, 96 microplate
HPG20096PSCLMID - Medium confluency, 96 microplate
HPG20096PSCLLOW - Low confluency, 96 microplate
HPG20024PSCLHIG - High confluency, 24 microplate
HPG20024PSCLMID - Medium confluency, 24 microplate
HPG20024PSCLLOW - Low confluency, 24 microplate
-
-80°C Freezer. Use by the expiry date on the packaging.
-
Eagle's minimum essential medium supplemented with 10% fetal bovine serum, 1% MEM non-essential amino acids and 1% antibiotic-antimyotic solution (optional).
Contact us.
High-quality content, relevant news and updates. No spam, only once a month! Unsubscribe anytime.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.